SurModics, Inc. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
SummaryPharmaceuticals and Healthcare
Key Findings
Pharmaceuticals and Healthcare
Pharmaceuticals and Healthcare
Reasons To Buys
MarketLine
Key Highlights
United States
Surmodics is a provider of medical device and in vitro diagnostic technologies to the healthcare industry. The company's segments are comprised of: Medical Device, which provides surface coatings and device drug-delivery technologies that impart lubricity, prohealing or biocompatibility characteristics, as well as drug delivery capabilities; and In Vitro Diagnostics (IVD), in which the company manufactures and sells components for IVD immunoassay and molecular tests and the company sells these components to the diagnostic, biomedical research, and life science markets. The company also provides colorimetric and chemiluminescent substrates to the IVD market under its BioFX? trademark.
MarketLine, a world-leading provider of commercial intelligence, has over 400 experienced analysts, consultants, and researchers with regional and sector expertise in market sizing, competitor tracking, socio and macro economics, and business drivers.
For more than 15 years MarketLine has supported the research needs of investment banks, corporations, professional services firms, and academia with a unique mix of company, industry, country, city and financial data for every major industry and marketplace.
MarketLine’ holistic business intelligence report collection includes:
Industry Intelligence
‒ Industry Profiles
‒ Market Forecasts
‒ Porter’s Five Forces Analysis
Company Intelligence
‒ Company Profiles
‒ SWOT Analysis
‒ Financial Deals
Country and City Intelligence
‒ Country and City Profiles
‒ PEST/PESTLE Analysis
‒ Socio and macro-economic indicators
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.